Neurotransmission-Related Genetic Polymorphisms, Negative Affectivity Traits, and Gender Predict Tobacco Abstinence Symptoms Across 44 Days With and Without Nicotine Patch

Journal of Abnormal Psychology

Volumn 118, Issue 2, 2009, Pages 322-334

  Gilbert, David G ^a   Zuo, Yantao ^b   Rabinovich, Norka E ^a   Riise, Hege ^a   Needham, Rachel ^a   Huggenvik, Jodi I ^c  

^a SOUTHERN ILLINOIS UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DRD2 genotype; negative affect; nicotine replacement therapy; serotonin transporter; smoking cessation

Indexed keywords

DOPAMINE 2 RECEPTOR; NICOTINE; NICOTINE PATCH; PLACEBO; SEROTONIN TRANSPORTER;

ADULT; ALLELE; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EMOTIONAL DISORDER; FEMALE; FINANCIAL MANAGEMENT; GENETIC POLYMORPHISM; GENETIC TRAIT; GENOTYPE; HETEROZYGOTE; HUMAN; INDIVIDUALITY; MAJOR CLINICAL STUDY; MALE; NEUROTRANSMISSION; NICOTINE REPLACEMENT THERAPY; PERSONALITY; PREDICTION; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; STRESS; TOBACCO DEPENDENCE; TREATMENT DURATION;

EID: 65649108089     PISSN: 0021843X     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0015382     Document Type: Article

References (63)

1. Baker T.B., Piper M.E., Fiore M.C., McCarthy D.E., and Majeskie M.R. Addiction motivation reformulated: An affective processing model of negative reinforcement. Psychological Review 111 (2004) 33-51
2. Beck A.T., Epstein N., Brown G., and Steer R.A. An inventory for measuring anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology 56 (1988) 893-897
3. Beck A.T., Steer R.A., and Brown G.A. BDI-II, Beck Depression Inventory: Manual (1996), Psychological Corporation, San Antonio, TX
4. Benwell M.E., and Balfour D.J. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. British Journal of Pharmacology 105 (1992) 849-856
5. Berrettini W.H., and Lerman C.E. Pharmacotherapy and pharmacogenetics of nicotine dependence. American Journal of Psychiatry 162 (2005) 1441-1451
6. Blum K., Braverman E.R., Holder J.M., Lubar J.F., Monastra V.J., Miller D., et al. Reward deficiency syndrome: A biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. Journal of Psychoactive Drugs 32 Suppl. i-iv (2000) 1-112
7. Carmody T.P. Affect regulation, nicotine addiction, and smoking cessation. Journal of Psychoactive Drugs 21 (1989) 331-342
8. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 301 (2003, July 18) 386-389
9. Cinciripini P.M., Wetter D.W., Tomlinson G.E., Tsoh J.Y., De Moor C.A., Cinciripini L.G., and Minna J.D. The effects of the DRD2 polymorphism on smoking cessation and negative affect: Evidence for a pharmacogenetic effect on mood. Nicotine and Tobacco Research 6 (2004) 229-239
10. Corrigall W.A., Coen K.M., and Adamson K.L. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Research 653 (1994) 278-284
11. Costa Jr. P.T., and McCrae R.R. Revised NEO Personality Inventory and Five-Factor Inventory Professional Manual (1992), Psychological Assessment Resources, Odessa, FL
12. Covey L.S., Glassman A.H., and Stetner F. Depression and depressive symptoms in smoking cessation. Comprehensive Psychiatry 31 (1990) 350-354
13. David S.P., Strong D.R., Munafò M.R., Brown R.A., Lloyd-Richardson E.E., Wileyto P.E., et al. Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: Analysis of pooled data from two clinical trials. Nicotine & Tobacco Research 12 (2007) 1251-1257
14. Eysenck H.J. The causes and effects of smoking (1980), Maurice Temple Smith, London
15. Fowler J.S., Volkow N.D., Wang G.-J., Pappas N., Logan J., MacGregor R.R., et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature 379 (1996, February 22) 733-736
16. Gallinat J., Meisenzahl E., Jacobsen L.K., Kalus P., Bierbrauer J., Kienast T., et al. Smoking and structural brain deficits: A volumetric MRI investigation. European Journal of Neuroscience 24 (2006) 1744-1750
17. Gilbert D.G. Smoking: Individual differences, psychopathology, and emotion (1995), Taylor & Francis, Washington, DC
18. Gilbert D.G., Crauthers D.M., Mooney D.K., McClernon F.J., and Jensen R.A. Effects of monetary contingencies on smoking relapse: Influence of trait depression, personality, and habitual nicotine intake. Experimental and Clinical Psychopharmacology 7 (1999) 174-181
19. Gilbert D.G., and Gilbert B.O. Personality, psychopathology, and nicotine response as mediators of the genetics of smoking. Behavior Genetics 25 (1995) 133-147
20. Gilbert D.G., and McClernon F.J. A smoke cloud of confusion. American Psychologist 55 (2000) 1158-1159
21. Gilbert D.G., McClernon F.J., Rabinovich N.E., Dibb W.D., Plath L.C., Hiyane S., et al. EEG, physiology, and task-related mood fail to resolve across 31 days of smoking abstinence: Relations to depressive traits, nicotine exposure, and dependence. Experimental and Clinical Psychopharmacology 7 (1999) 427-443
22. Gilbert D.G., McClernon F.J., Rabinovich N.E., Plath L.C., Jensen R.A., and Meliska C.J. Effects of smoking abstinence on mood and craving in men: Influences of negative-affect-related personality traits, habitual nicotine intake, and repeated measurements. Personality and Individual Differences 25 (1998) 399-423
23. Gilbert D.G., McClernon F.J., Rabinovich N., Plath L.C., Masson C.L., Anderson A.E., and Sly K.F. Mood disturbance fails to resolve across 31 days of cigarette abstinence in women. Journal of Consulting and Clinical Psychology 70 (2002) 142-152
24. Gilbert D.G., McClernon F.J., Rabinovich N.E., Sugai C., Plath L.C., Asgaard G., et al. Effects of quitting smoking on EEG activation and attention last for more than 31 days and are more severe with stress, dependence, DRD2 A1 allele, and depressive traits. Nicotine and Tobacco Research 6 (2004) 249-267
25. Glazier A.M., Nadeau J.H., and Aitman T.J. Finding genes that underlie complex traits. Science 298 (2002, December 20) 2345-2349
26. Hariri A.R., and Holmes A. Genetics of emotional regulation: The role of the serotonin transporter in neural function. Trends in Cognitive Sciences 10 (2006) 182-191
27. Harrison A.A., Liem Y.T.B., and Markou A. Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. Neuropsychopharmacology 25 (2001) 55-71
28. Heath A.C., Madden P.A.F., Slutske W.S., and Martin N.G. Personality and the inheritance of smoking behavior: A genetic perspective. Behavior Genetics 25 (1995) 103-117
29. Heath A.C., Neale M.C., Kessler R.C., Eaves L.J., and Kendler K.S. Evidence of genetic influences on personality from self-reports and informant ratings. Journal of Personality and Social Psychology 63 (1992) 85-96
30. Heatherton T.F., Kozlowski L.T., Frecker R.C., and Fagerström K.O. The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction 86 (1991) 1119-1127
31. Hu S., Brody C.L., Fisher C., Gunzerath L., Nelson M.L., Sabol S.Z., et al. Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior. Molecular Psychiatry 5 (2000) 181-188
32. Jacob P., Wilson M., and Benowitz N. Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. Journal of Chromatography 222 (1981) 61-70
33. Jamner L.D., Shapiro D., and Jarvik M.E. Nicotine reduces the frequency of anger reports in smokers and nonsmokers with high but not low hostility: An ambulatory study. Experimental and Clinical Psychopharmacology 7 (1999) 454-463
34. Johnstone E.C., Yudkin P.L., Hey K., Roberts S.J., Welch S.J., Murphy M.F., et al. Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. Pharmacogenetics 14 (2004) 83-90
35. Kendler K.S., Neale M.C., MacLean C.U., Heath A.C., Eaves L.J., and Kessler R.C. Smoking and major depression: A causal analysis. Archives of General Psychiatry 50 (1993) 36-43
36. Lerman C., Caporaso N.E., Audrain J., Main D., Boyd N.R., and Shields P.G. Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Molecular Psychiatry 5 (2000) 189-192
37. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996, November 29) 1527-1531
38. Lesch K.P., and Merschdorf U. Impulsivity, aggression, and serotonin: A molecular psychobiological perspective. Behavioral Sciences & the Law 18 (2000) 581-604
39. McClernon F.J., Hiott F.B., Westman E.C., Rose J.E., and Levin E.D. Transdermal nicotine attenuates depression symptoms in nonsmokers: A double-blind, placebo-controlled trial. Psychopharmacology 189 (2006) 125-133
40. McNair D.M., Lorr M., and Droppleman L.F. Manual: Profile of Mood States (1971), Educational and Industrial Testing Service, San Diego, CA
41. Munafò M.R., Clark T.G., Johnstone E.C., Murphy M.F.G., and Walton R. Genetic polymorphisms and smoking behaviour: A systematic review and meta-analysis. Nicotine & Tobacco Research 6 (2004) 583-597
42. Munafò M.R., Roberts K., Johnstone E.C., Walton R.T., and Yudkin P.L. Association of serotonin transporter gene polymorphism with nicotine dependence: No evidence for an interaction with trait neuroticism. Personality and Individual Differences 38 (2005) 843-850
43. Neuhaus A., Bajbouj M., Kienast T., Kalus P., von Haebler D., Winterer G., and Gallinat J. Persistent dysfunctional frontal lobe activation in former smokers. Psychopharmacology 186 (2006) 191-200
44. Neville M.J., Johnstone E.C., and Walton R.T. Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Human Mutation 23 (2004) 540-545
45. Pergadia M.L., Heath A.C., Martin N.G., and Madden P.A.F. Genetic analyses of DSM-IV nicotine withdrawal in adult twins. Psychological Medicine 36 (2006) 963-972
46. Perkins K.A., and Scott J. Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine & Tobacco Research 10 (2008) 1245-1251
47. Piasecki T.M., and Baker T.B. Does smoking amortize negative affect?. American Psychologist 55 (2000) 1156-1157
48. Piasecki T.M., Jorenby D.E., Smith S.S., Fiore M.C., and Baker T.B. Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. Journal of Abnormal Psychology 112 (2003) 3-13
49. Piasecki T.M., Jorenby D.E., Smith S.S., Fiore M.C., and Baker T.B. Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations. Journal of Abnormal Psychology 112 (2003) 14-27
50. Piasecki T.M., Jorenby D.E., Smith S.S., Fiore M.C., and Baker T.B. Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity. Experimental and Clinical Psychopharmacology 11 (2003) 276-285
51. Piasecki T.M., Niaura R., Shadel W.G., Abrams D., Goldstein M., Fiore M.C., and Baker T.B. Smoking withdrawal dynamics in unaided quitters. Journal of Abnormal Psychology 109 (2000) 74-86
52. Raudenbush S.W., and Bryk A.S. Hierarchical linear models: Applications and data analysis method. 2nd ed. (2002), Sage, Newbury Park, CA
53. Ribeiro E.B., Bettiker R.L., Bogdanov M., and Wurtman R.J. Effects of systemic nicotine on serotonin release in rat brain. Brain Research 621 (1993) 311-318
54. Schmitz A., Hennig J., Kuepper Y., and Reuter M. The association between neuroticism and the serotonin transporter polymorphism depends on structural differences between personality measures. Personality and Individual Differences 42 (2007) 789-799
55. Shiffman S. The tobacco withdrawal syndrome. In: Krasnegor N.A. (Ed). Cigarette smoking as a dependence process (1979), Public Health Service, Rockville, MD 153-184 NIDA Research Monograph No. 23
56. Shiffman S., and Waters A.J. Negative affect and smoking lapses: A prospective analysis. Journal of Consulting and Clinical Psychology 72 (2004) 192-201
57. Shiffman S., West R.J., and Gilbert D.G. Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials. Nicotine & Tobacco Research 6 (2004) 599-614
58. Snyder F.R., Davis F.C., and Henningfield J.E. The tobacco withdrawal syndrome: Performance decrements assessed on a computerized test battery. Drug and Alcohol Dependence 23 (1989) 259-266
59. Spielberger C.D. Revised State-Trait Personality Inventory (Revised STPI) (1995), Mind Garden, Palo Alto, CA
60. Spitz M.R., Shi H., Yang F., Hudmon K.S., Jiang H., Chamberlain R.M., et al. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. Journal of the National Cancer Institute 90 (1998) 358-363
61. Thompson J., Thomas N., Singleton A., Piggot M., Lloyd S., Perry E.K., et al. D2 dopamine receptor gene (DRD2) Taq1A polymorphism: Reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7 (1997) 470-484
62. Yonan A.L., Palmer A.A., and Gilliam T.C. Hardy-Weinberg disequilibrium identified genotyping error of the serotonin transporter (SLC6A4) promoter polymorphism. Psychiatric Genetics 16 (2006) 31-34
63. Zvolensky M.J., Lejuez C.W., Kahler C.W., and Brown R.A. Nonclinical panic attack history and smoking cessation: An initial examination. Addictive Behaviors 29 (2004) 825-830